Evidence map›Paper›PMID 40313319›Full record

ArticleRSC advances2025

Study of conductive nerve conduits for anti-inflammatory and antioxidant effects.

Runtian Xu, Hanping He, Huan Deng, Yuehan Dong, Xiangjie Wu, Zinuo Xia, Yang Zhou, Lin Yang, Zhijun Huang, Wenjin Xu and 2 more

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Runtian XuDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.ORCID https://orcid.org/0009-0009-9106-3368
Hanping HeDepartment of Radiation Oncology, Hubei Cancer Hospital Wuhan 430079 China.
Huan DengDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.
Yuehan DongDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.
Xiangjie WuDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.
Zinuo XiaDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.
Yang ZhouDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.
Lin YangDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.
Zhijun HuangDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.
Wenjin XuDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.ORCID https://orcid.org/0000-0001-6445-478X
Peihu XuDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.ORCID https://orcid.org/0009-0001-6895-3858
Haixing XuDepartment of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering, and Life Sciences, Wuhan University of Technology Wuhan 430070 China xhx040328@whut.edu.cn whutxph68@126.com.ORCID https://orcid.org/0000-0002-0150-8645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Replacing autologous nerve grafts with nerve conduits is the prevailing direction for the treatment of peripheral nerves, though the repair of hollow nerve conduits remains unsatisfactory. In this study, cysteinylated zein (l-Zein) was prepared through a disulfide exchange reaction between the disulfide bonds of cysteine (Cys) and those of zein (Zein). Subsequently, electrospinning was utilized to fabricate hollow nerve conduits loaded with berberine (BBR) by means of hydrogen bonding and physical encapsulation. Hydrogels were prepared by ionic cross-linking of Zein with pectin (Pec), and were subsequently loaded with melatonin (MT) and graphene oxide (GO) through physical adsorption and encapsulation. A hydrogel was then injected into a hollow catheter to form a hydrogel composite nerve conduit (l-ZBZPGM). The hydrogels exhibited a continuous porous network structure with pore size distribution between 100 and 200 μm. Most of the hydrogels exhibited porosity exceeding 70% and the compressive modulus was 0.42 ± 0.025 MPa. A hydrogel exhibited a residual mass ratio of 35.15% ± 1.87% at the end of the 30 d degradation period, achieved peak release on day 18 with a release rate of 83.31% ± 3.64%, and had an electrical conductivity of 1.23 ± 0.482 × 10

Identifiers

PMID40313319
PMCPMC12044412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.